On Monday, in the course of current trade, Shares of Exxon Mobil Corporation (NYSE:XOM), climbed 1.86%, and is now trading at $78.27.
ExxonMobil will add flexibility to process light crudes at its Beaumont refinery, increasing production capacity by about 20,000 barrels per day. This expansion will further strengthen ExxonMobil’s integrated downstream portfolio in Southeast Texas.
“This project will grow our capacity and flexibility to process light crude oils,” said Jerry Wascom, president of ExxonMobil Refining and Supply Company. “Building on the recent enhances in domestic oil and gas production, this investment further strengthens the competitiveness of the company’s planned assets in North America and enhances U.S. energy security.”
Exxon Mobil Corporation explores for and produces crude oil and natural gas in the United States, Canada/South America, Europe, Africa, Asia, and Australia/Oceania. It also manufactures and markets commodity petrochemicals, counting olefins, aromatics, polyethylene and polypropylene plastics, and specialty products; and transports and sells crude oil, natural gas, and petroleum products.
During an Afternoon trade, Shares of CyrusOne Inc (NASDAQ:CONE), climbed 2.56%, and is now trading at $31.60.
CyrusOne Inc., which specializes in providing highly reliable enterprise-class, carrier-neutral data center properties to the Fortune 1000, declared second quarter 2015 earnings.
Second Quarter 2015 Financial Results
Revenue was $89.1 million for the second quarter, contrast to $81.7 million for the same period in 2014, an enhance of 9%. Operating income of $2.6 million reduced $4.8 million from the second quarter of 2014, driven by an $8.8 million enhance in transaction costs primarily related to the Cervalis acquisition, in addition to enhances in depreciation and amortization of $1.6 million, property operating expenses of $1.0 million, and selling, general and administrative expenses of $0.8 million, partially offset by a $7.4 million enhance in revenue. Net loss was $6.5 million for the second quarter, contrast to net loss of $3.6 million for the same period in 2014. The $2.9 million enhance in net loss was driven by the decrease in operating income, partially offset by a $2.0 million reduction in interest expense.
CyrusOne Inc., a real estate investment trust (REIT), owns, operates, and develops enterprise-class, carrier-neutral, and multi-tenant data center properties. The company provides mission-critical data center facilities that protect and ensure the continued operation of information technology infrastructure.
Finally, MEI Pharma Inc (NASDAQ:MEIP), lost -3.49% Monday.
MEI Pharma, declared that Daniel P. Gold, Ph.D., President and Chief Executive Officer, will present at the 2015 Wedbush PacGrow Healthcare Conference on Tuesday, August 11, 2015 at 3:40 p.m. Eastern time from Le Parker Meridien in New York.
MEI Pharma, Inc., an oncology company, focuses on the clinical development of novel therapies for the treatment of cancer. The company’s lead drug candidate is Pracinostat, an orally accessible histone deacetylase inhibitor, which is in Phase II clinical trial for the treatment of hematologic diseases, such as myelodysplastic syndrome and acute myeloid leukemia.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
